Anoscopy Genius @ ACG Congress 2023
October 23, 2023
Anal cancer diagnosis is challenging, specially when considering anal cancer percursors. DIGESTAID is thrilled to
Menu
Menu
Welcome to our journal
Here you will find news and scientific articles related to DIGESTAID or AI in Gastroenterology
Anal cancer diagnosis is challenging, specially when considering anal cancer percursors. DIGESTAID is thrilled to
We’re proud to share that our research in evaluating inflammatory activity in Crohn’s disease using
The buzz is building, and we’re thrilled to share that DigestAid has been generating immense
We’re going transatlantic! DigestAID team is excited to share our participation in the prestigious American
DigestAID’s CEO, Dr. Miguel Mascarenhas, had the privilege of delivering a lecture titled “AI in
Anticipation builds as DIGESTAID prepares for UEG Week 2023 in Copenhagen (Oct 14- 17). Our
Exciting news! DigestAID CEO, Dr. Miguel Mascarenhas, has been nominated in the Young Talent Category
New paper out! We are thrilled to announce a pivotal achievement with our latest publication
We are excited to announce that DigestAID has been selected to join the Endless Frontier Labs 2023-2024
Anal cancer diagnosis is challenging, specially when considering anal cancer percursors. DIGESTAID is thrilled to
We’re proud to share that our research in evaluating inflammatory activity in Crohn’s disease using
The buzz is building, and we’re thrilled to share that DigestAid has been generating immense
We’re going transatlantic! DigestAID team is excited to share our participation in the prestigious American
DigestAID’s CEO, Dr. Miguel Mascarenhas, had the privilege of delivering a lecture titled “AI in
Anticipation builds as DIGESTAID prepares for UEG Week 2023 in Copenhagen (Oct 14- 17). Our
Exciting news! DigestAID CEO, Dr. Miguel Mascarenhas, has been nominated in the Young Talent Category
New paper out! We are thrilled to announce a pivotal achievement with our latest publication
We are excited to announce that DigestAID has been selected to join the Endless Frontier Labs 2023-2024
